Navigation Links
Echo Therapeutics Announces First Quarter 2012 Financial Results
Date:5/11/2012

rent Liabilities:Accounts payable

$
36,658$
365,298Deferred revenue

123,708123,708Derivative warrant liability

803,7941,035,337Accrued expenses and other liabilities

389,059968,120Total current liabilities

1,953,2192,492,463Deferred revenue, notes payable and capital lease obligation, net of current portion and discounts

34,22065,755Total liabilities

1,987,4392,558,218CommitmentsStockholders' Equity:Convertible preferred stock, Series C & D

30,16030,160Common stock

388,363385,442Additional paid-in capital

98,634,01798,116,327Common stock subscribed for but not paid for or issued

-6,667Accumulated deficit

(84,555,777)(81,570,007)Total stockholders' equity

14,496,76316,968,589Total liabilities and stockholders' equity

$
,484,202$
9,526,807Condensed Consolidated Statements of OperationsThree Months Ended March 31,20122011Licensing revenue

$
30,927$
21,455Other revenue

-108,087Total revenues

30,927229,542Operating Expenses:Research and development

1,391,645865,950Selling, general and administrative

1,859,404918,750Total operating expenses

3,251,0491,784,700Loss from operations

(3,220,122)(1,555,158)Other Income (Expense):Interest income (expense), net

2,809(10,671)Loss on extinguishment of debt/payables

-(1,514)Derivative warrant liability gain (loss)

231,543(3,029,897)Other income (expense), net

234,352(3,042,082)Net loss

(2,985,770)(4,597,240)Deemed dividend on beneficial conversion feature of Series D Convertible Preferred Stock

-(1,975,211)Accretion of dividends on Convertible Perpetual Redeemable Preferred Stock

-(45,684)Net loss applicable to common shareholders

$
(2,985,770)$
(6,618,135)Net loss per common share, basic and diluted

$
(0.08)$
(0.20)Basic and dil
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
2. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
3. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
4. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
5. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
7. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
8. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
9. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
10. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
11. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... BOSTON , May 17, 2013  TechAtlas ... update for their competitive landscape map for the ... highlights over 90 international companies with drugs and ... addressing CKD and its sequelae. ... include: , hypertension - renal denervation ...
(Date:5/17/2013)... Fuse Science, Inc. (OTCQB: DROP), ( www.fusescience.com ) ... new, patent-pending technologies poised to redefine how consumers receive energy, ... a business update teleconference and webcast for shareholders and the ... 4:30 PM ET. Fuse Science, Inc. CEO, ... and will be joined by Rubin Hanan ...
(Date:5/17/2013)... -- Sanofi (EURONEXT: SAN and NYSE: SNY ) announced ... , examining the selective JAK2 inhibitor SAR302503 for myelofibrosis ... The primary endpoint assessed the proportion of patients achieving ... in previous trials, the most common adverse events were ... presented at an upcoming medical congress. ...
Breaking Medicine Technology:TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6
(Date:5/19/2013)... People in Minnesota have a great option to get in ... Day Fat Loss Formula. The best part is people ... home. The product sells for $135 dollars and is an ... http://altmanfitness.com/28-day-fat-loss-formula/ , “Bikini season is almost here. People ... using the 28 Day Fat Loss Formula they will be ...
(Date:5/19/2013)... City, Utah (PRWEB) May 19, 2013 ... information on small business health insurance . ... to traditional employer sponsored health benefits, is the ... and health reimbursement arrangements . , ... start-ups, and the self-employed intrinsically know the value ...
(Date:5/19/2013)... May 19, 2013 These molecular ... US, UK, Spain, Japan, Italy, Germany and France:, ... molecular diagnostics laboratory practice, as well as key ... significant market impact during the next five years. ... and biochip technologies, test formats, detection methodologies, trends ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Americans live ... to the newest American Veterinary Medical Association (AVMA) U.S. ... American dog owners consider their dog a member of ... had said as much five years earlier. , According ... value of the national income dedicated to pets has ...
(Date:5/19/2013)... Las Vegas, Nevada (PRWEB) May 19, 2013 ... travel agency , is proud to announce the launch ... Music Awards at the MGM Grand on 5/19/2013. Consumers ... the all new special pricing available on VegasHotelEscapes.com's website. ... guarantee that they beat any competitors price. , Vegas ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 2Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 3
... Feb. 10 During scheduled visits to Members of ... Homecare and its members will urge Congress and the ... the Medicare Anti-Fraud Legislative Plan. Developed by the ... tough, effective measures to stop waste, fraud and abuse ...
... researchers say , , TUESDAY, Feb. 10 (HealthDay News) -- ... even bother to use them because they,re difficult to ... are allowing the brain to communicate directly with artificial ... banana and fold laundry. , "In the simplest terms, ...
... even if you stop taking the drug, study finds , , ... aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) appears to reduce ... cancer. , That,s the conclusion of a new study of ... clear, and arguably proven, that NSAID drugs do interfere with ...
... of Potential Surrogate Endpoints of Long-Term Survival in Prostate ... distant metastases 3 years after the start of treatment ... with early prostate cancer. , Prostate cancer is a ... history of the disease makes evaluation of new therapies ...
... percent as a result of My Health programLOS ... Institute (IBI) and the National Business Coalition on ... the 2009 IBI/NBCH Healthy Workforce Productivity Award at ... 9-11 in Los Angeles. The award, sponsored by ...
... to have an effect on whether a patient with terminal ... by researchers at Beth Israel Deaconess Medical Center (BIDMC). Published ... the American Geriatrics Society ( JAGS ), the findings ... services less frequently than do whites and Hispanics. , According ...
Cached Medicine News:Health News:American Association for Homecare Proposes to Congress a Medicare Anti-Fraud Action Plan that Includes Increased Penalties, Site Inspection, and Tough Standards 2Health News:American Association for Homecare Proposes to Congress a Medicare Anti-Fraud Action Plan that Includes Increased Penalties, Site Inspection, and Tough Standards 3Health News:American Association for Homecare Proposes to Congress a Medicare Anti-Fraud Action Plan that Includes Increased Penalties, Site Inspection, and Tough Standards 4Health News:New Technology May Boost Artificial Arms 2Health News:Long-Term Aspirin Use Seems to Protect Against Colorectal Lesions 2Health News:Long-Term Aspirin Use Seems to Protect Against Colorectal Lesions 3Health News:Also in the Feb. 10 JNCI 2Health News:Also in the Feb. 10 JNCI 3Health News:Also in the Feb. 10 JNCI 4Health News:Also in the Feb. 10 JNCI 5Health News:Nationwide Receives IBI/NBCH Healthy Workforce Productivity Award 2Health News:Nationwide Receives IBI/NBCH Healthy Workforce Productivity Award 3Health News:Study finds race and ethnicity affect use of hospice services among patients with advanced cancer 2
6 mm x 23 mm blunt, double-edged blade. Flat handle....
7 mm blade, angled right. Flat handle....
5 mm x 8 mm "D" shaped knife. Flat handle. Designated most popular model or size....
1 mm diameter. Angled 33 degrees. Round handle....
Medicine Products: